The government’s complaint alleges that, from Oct. 17, 2013, to the present, CVS knowingly filled prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid and/or were not issued in the usual course of professional practice.
Looking to offset declining margins, generic drug suppliers are diversifying capabilities and emphasizing specialty products, biosimilars and patient services.
